Management of difficult-to-treat atopic dermatitis

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 2, 2013, Pages 142-151

  Arkwright, Peter D ^a   Motala, Cassim ^b   Subramanian, Hamsa ^c   Spergel, Jonathan ^d   Schneider, Lynda C ^e   Wollenberg, Andreas ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Signature Allergy Immunology   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atopic dermatitis; Compliance; Corticosteroids; Cyclosporine; Eczema; Review; Tacrolimus

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; FOOD ALLERGEN; METHOTREXATE; PIMECROLIMUS; PLACEBO; TACROLIMUS;

ACNE; ALLERGIC REACTION; ALTERNATIVE MEDICINE; ARTICLE; ATOPIC DERMATITIS; BACTERIAL SKIN DISEASE; DIAGNOSTIC ERROR; DIET RESTRICTION; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG SAFETY; FOOD ALLERGY; HUMAN; HYPOPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PHOTOTHERAPY; PRURITUS; SECONDARY INFECTION; SKIN ATROPHY; SOCIAL PSYCHOLOGY; STRIA; SUBCUTANEOUS IMMUNOTHERAPY; T LYMPHOCYTE ACTIVATION;

ATOPIC DERMATITIS; COMPLIANCE; CORTICOSTEROIDS; CYCLOSPORINE; ECZEMA; REVIEW; TACROLIMUS;

ADRENAL CORTEX HORMONES; DERMATITIS, ATOPIC; DRUG HYPERSENSITIVITY; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC;

EID: 84877992939     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2012.09.002     Document Type: Article

References (101)

1. Hanifin J.M., Reed M.L. Eczema prevalence and impact working group. A population-based survey of eczema prevalence in the United States. Dermatitis 2007, 18:82-91.
2. Peroni D.G., Placentini G.L., Bodini A., Rigotti E., Pigozzi R., Boner A.L. Prevalence and risk factors for atopic dermatitis in preschool children. Br J Dermatol 2008, 158:539-543.
3. Willemsen M.G., van Valburg R.M., Dirven-Meijer P.C., Oranje A.P., van der Wouden J.C., Moed H. Determining the severity of atopic dermatitis in children presenting in general practice: an easy and fast method. Dermatol Res Pract 2009, 2009:357046.
4. Horii K.A., Simon S.D., Liu D.Y., Sharma V. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatr 2007, 120:e527-e534.
5. Mancini A.J., Laulback K., Chamlin S.L. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008, 25:1-6.
6. Hanifin J.M., Rajka G. Diagnostic features of atopic eczema. Acta Dermatol Venereol (Stockh) 1980, 92:44-47.
7. Williams H.C., Burney P.G.J., Hay R.J., Archer C.B., Shipley M.J., Hunter J.J., et al. The UK Working Party's Diagnostic criteria for atopic dermatitis I: derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994, 131:383-396.
8. Eichenfield F., Hanifin J., Luger T., Stevens S., Pride H. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003, 49:1088-1095.
9. Ellis R.M., Koch L.H., McGuire E., Williams J.V. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 2011, 28:242-244.
10. Zuberbeir T., Orlow S.J., Paller A.S., Taieb A., Allen R., Hernanz-Hermosa J.M., et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006, 118:226-232.
11. Krejci-Manwaring J., Tusa M.G., Carroll C., Camacho F., Kaur M., Carr D., et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2007, 56:211-216.
12. Moore E., Williams A., Manias E., Varigos G. Nurse-led clinics reduce severity of childhood atopic eczema: a review of the literature. Br J Dermatol 2006, 155:1242-1248.
13. Ohya Y., Williams H., Steptoe A., Saito H., Iikura Y., Anderson R., et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001, 117:852-857.
14. Cork M.J., Britton J., Butler L., Young S., Murphy R., Keohane S.G. Comparison of parental knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003, 149:582-589.
15. Ntuen E., Taylor S.L., Kinney M., O'Neill J.L., Krowchuk D.P., Feldman S.R. Physicians' perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat 2010, 21:28-33.
16. Karlberg A.T., Bergstrom M.A., Borje A., Luthman K., Nilsson J.L. Allergic contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 2008, 21:53-69.
17. Coloe J., Zirwas M.J. Allergens in corticosteroid vehicles. Dermatitis 2008, 19:38-42.
18. Hogan D.J. Allergic contact dermatitis to ethylenediamine. A continuing problem. Dermatol Clin 1990, 133-136.
19. Corazza M., Mantovani L., Maranini C., Bacilieri S., Virgili A. Contact sensitization to corticosteroids: increased risk in long term dermatoses. Eur J Dermatol 2000, 10:533-535.
20. Camacho-Halili M., Axelrod S., Michelis M.A., Lighvani S., Khan F., Leon S., et al. A multi-center, retrospective review of patch testing for contact dermatitis in allergy practices. Ann Allergy Asthma Immunol 2011, 107:487-492.
21. Breuer K., Haussler S., Kapp A., Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002, 147:55-61.
22. Roll A., Cozzio A., Fischer B., Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004, 4:373-378.
23. Ong P.Y., Leung D.Y. The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am 2010, 30:309-321.
24. Morishita Y., Tada J., Sato A., Toi Y., Kanzaki H., Akiyama H., et al. Possible influences of Staphylococcus aureus on atopic dermatitis-the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999, 29:1110-1117.
25. Cardona I.D., Cho S.H., Leung D.Y. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 2006, 7:273-279.
26. Leung A.D., Schiltz A.M., Hall C.F., Liu A.H. Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus. Clin Exp Allergy 2008, 38:789-793.
27. Adachi J., Endo K., Fukuzumi T., Tanigawa N., Aoki T. Increasing incidence of streptococcal impetigo in atopic dermatitis. J Dermatol Sci 1998, 17:45-53.
28. Arkwright P.D., Daniel T.O., Sanyal D., David T.J., Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 2002, 138:939-941.
29. Chung H.J., Jeon H.S., Sung H., Kim M.N., Hong S.J. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol 2008, 46:991-995.
30. Wollenberg A., Wetzel S., Burgdorf W.H., Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003, 112:667-674.
31. Darabi K., Hostetler S.G., Bechtel M.A., Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009, 60:125-136.
32. Boguniewicz M., Leung D.Y. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010, 125:4-13.
33. Forbes L.R., Salzman R.W., Spergel J.M. Food allergies and atopic dermatitis: differentiating myth from reality. Pediatr Ann 2009, 38:84-90.
34. Breuer K., Heratizadeh A., Wulf A., Baumanm U., Constien A., Tetau D., et al. Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy 2004, 34:817-824.
35. Kerschenlohr K., Decard S., Darsow U., Ollert M., Wollenberg A. Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients. J Allergy Clin Immunol 2003, 111:195-197.
36. Kerschenlohr K., Darsow U., Burgdorf W.H., Ring J., Wollenberg A. Lessons of atopy patch testing in atopic dermatitis. Curr Allergy Asthma Rep 2004, 4:285-289.
37. Darsow U., Laifaoui J., Kerschenlohr K., Wollenberg A., Przybilla B., Wüthrich B., et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004, 59:1318-1325.
38. Mehl A., Rolinck-Werninghaus C., Staden U., Verstege A., Wahn U., Beyer K., et al. The atopy patch test in the diagnostic workup of suspected food-related symptoms in children. J Allergy Clin Immunol 2006, 118:923-929.
39. Gavino A.C., Needham G.R., High W.A. Atopic dermatitis, patch testing, and house dust mites: a brief review. Dermatitis 2008, 19:121-128.
40. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A., et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010, 126:S1-58. NIAID-Sponsored Expert Panel.
41. Bath-Hextall F., Delamere F.M., Williams H.C. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev 2008, (1):CD005203.
42. Hoare C., Li Wan Po A., Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000, 4:1-191.
43. Tupker R.A., De Monchy J.G., Coenraads P.J., Homan A., van der Meer J.B. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996, 97:1064-1070.
44. Gutgesell C., Heise S., Seubert S., Seubert A., Domhof S., Brunner E., et al. Double-blind placebo controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001, 145:70-74.
45. Oosting A.J., de Bruin-Weller M.S., Terreehorst I., Tempels-Pavlica Z., Aaberse R.C., de Monchy J.G., et al. Effect of mattress encasements on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002, 110:500-506.
46. Tan B.B., Weald D., Strickland I., Friedmann P.S. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996, 347:15-18.
47. Langan S.M., Williams H.C. What causes worsening of eczema? A systematic review. Br J Dermatol 2006, 155:504-514.
48. Moore K., David T.J., Murray C.S., Child F., Arkwright P.D. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 2006, 154:514-518.
49. Meltzer L.J., Moore M. Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. J Pediatr Psychol 2008, 33:279-291.
50. Wittkowski A., Richards H.L., Griffiths C.E., Main C.J. Illness perception in individuals with atopic dermatitis. Psychol Health Med 2007, 12:433-444.
51. Bockelbrink A., Heinrich J., Schäfer I., Zutavern A., Borte M., Herbarth O., et al. Atopic eczema in children: another harmful sequel of divorce. Allergy 2006, 61:1397-1402.
52. Zeppa L., Bellini V., Lisi P. Atopic dermatitis in adults. Dermatitis 2011, 22:40-46.
53. Darabi K., Hostetler S.G., Bechtel M.A., Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009, 60:125-136.
54. Chida Y., Steptoe A., Hirakawa N., Sudo N., Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 2007, 144:1-9.
55. Ersser S.J., Latter S., Sibley A., Satherley P.A., Welbourne S. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2007, (3):CD004054.
56. Staab D., Diepgen T.L., Fartasch M., Kupfer J., Lob-Corzilius T., Ring J., et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomized controlled trail. BMJ 2006, 332:933-938.
57. Gradwell C., Thomas K.S., English J.S., Williams H.C. A randomised controlled trial of nurse follow-up clinics: do they help patients and do they free up consultants' time?. Br J Dermatol 2002, 147:513-517.
58. Ehlers A., Strangier U., Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995, 63:624-635.
59. Williams H.C. Education programmes for young people with eczema. BMJ 2006, 332:923-924.
60. De Benedetto A., Kubo A., Beck L.A. Skin barrier disruption: a requirement for allergen sensitization?. J Invest Dermatol 2012, 132:949-963.
61. Irvine A.D., McLean W.H., Leung D.Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011, 365:1315-1327.
62. Lodén M. Effect of moisturizers on epidermal barrier function. Clin Dermatol 2012, 30:286-296.
63. Grimalt R., Mengeaud V., Cambazard F. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007, 214:61-67. Study Investigators' Group.
64. Szczepanowaska J., Reich A., Szepietowski J.C. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008, 19:614-618.
65. Simpson E., Böhling A., Bielfeldt S., Bosc C., Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat 2012 Sep 9, [Epub ahead of print].
66. Finlay A.Y. Defining the fingertip unit. BMJ 2012, 344:e3061.
67. Ring J., Alomar A., Bieber T., Deleuran M., Fink-Wagner A., Gelmetti C., et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012, 26:1045-1060.
68. Bornhövd E., Burgdorf W.H.C., Wollenberg A. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol 2001, 45:736-743.
69. National Institute of Health and Clinical Excellence. Atopic eczema in children. Management of atopic eczema in children from birth to the age of 12 years. NICE Clinical Guideline 57; 2007. Available from: 2010. Accessed December 5, 2012. http://guidance.nice.org.uk/CG57/NICEGuidance/pdf/English;.
70. Wollenberg A., Frank R., Kroth J., Ruzicka T. Proactive therapy of atopic eczema-an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges 2009, 7:117-121.
71. Wollenberg A., Reitamo S., Girolomoni G., Lahfa M., Ruzicka T., Healy E., et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008, 63:742-750.
72. Paller A.S., Eichenfield L.F., Kirsner R.S., Shull T., Jaracz E., Simpson E.L., et al. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics 2008, 122:1210-1218.
73. Thaci D., Reitamo S., Gonzalez Ensenat M.A., Moss C., Boccaletti V., Cainelli T., et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008, 159:1348-1356.
74. Harper J.I., Ahmed I., Barclay G., Lacour M., Hoeger P., Cork M.J., et al. Cyclosporin for severe childhood atopic dermatitis. Short course versus continuous therapy. Br J Dermatol 2000, 142:52-58.
75. Sowden J.M., Berth-Jones J., Ross J.S., Motley R.J., Marks R., Finlay A.Y., et al. Double-blind, controlled, crossover study of cyclosporine in adults with severe refractory atopic dermatitis. Lancet 1991, 338:137-140.
76. Beaumont D.R., Arkwright P.D. Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitis. J Dermatolog Treat 2012, 23:318-322.
77. Czech W., Bräutigam M., Weidinger G., Schöpf E. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol 2000, 42:653-659.
78. Berth-Jones J., Takwale A., Tan E., Barclay G., Agarwal S., Ahmed I., et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002, 147:324-330.
79. Patel A.N., Langan S.M., Batchelor J.M. A randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal. Br J Dermatol 2012, 166:701-704.
80. Schram M.E., Roekevisch E., Leeflang M.M., Bos J.D., Schmitt J., Spuls P.I. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011, 128:353-359.
81. Schmitt J., Schäkel K., Fölster-Holst R., Bauer A., Oertel R., Augustin M., et al. Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol 2010, 162:661-668.
82. Scheinfeld N.S., Tutrone W.D., Weinberg J.M., DeLeo V.A. Phototherapy of atopic dermatitis. Clin Dermatol 2003, 21:241-248.
83. Meduri N.B., Vandergiff T., Rasmussen H., Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007, 23:106-112.
84. Gauger A., Mempel M., Schekatz A., Schafer T., Ring J., Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003, 207:15-21.
85. Huang J.T., Abrams M., Tlougan B., Rademaker A., Paller A.S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatr 2009, 123:e808-e814.
86. Pei A.Y., Chan H.H., Ho K.M. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol 2001, 18:343-348.
87. Hindley D., Galloway G., Murray J., Gardener L. A randomised study of "wet wraps" versus conventional treatment for atopic eczema. Arch Dis Child 2006, 91:164-168.
88. Sampson H.A. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Immunol 1988, 81:635-645.
89. Sher L.G., Chang J., Patel I.B., Balkrishnan R. Relieving the pruritus of atopic dermatitis: a meta-analysis. Acta Derm Venereol 2012, 92:455-461.
90. Hughes R., Ward D., Tobin A.M., Keegan K., Kirby B. The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr Dermatol 2007, 24:118-120.
91. Li X.M. Complementary and alternative medicine in paediatric allergic disorders. Curr Opin Allergy Clin Immunol 2009, 9:161-167.
92. Zhang W., Leonard T., Bath-Hextall F., Chambers C.A., Lee C., Humphreys R., et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2004, (4):CD002291.
93. Tovar R.T. Clinical approach to clinical herbal toxicity. Semin Diagn Pathol 2009, 26:28-37.
94. Katoh N. Future perspectives in the treatment of atopic dermatitis. J Dermatol 2009, 36:367-376.
95. Bussmann C., Bockenhoff A., Henke H., Werfel T. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis. J Allergy Clin Immunol 2006, 118:1292-1298.
96. Pajno G.B., Caminiti L., Vita D., Barberio G., Salzano G., Lombardo F., et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007, 120:164-170.
97. Van der Aa L.B., Heymans H.A., van Aalderen W.M., Sprikkelman A.B. Probiotics and prebiotics in atopic dermatitis: review of the therapeutic background and clinical evidence. Pediatr Allergy Immunol 2010, 21(2 Pt 2):e355-e367.
98. Darsow U., Forer I., Ring J. Allergen-specific immunotherapy in atopic eczema. Curr Allergy Asthma Rep 2011, 11:277-283.
99. Boguniewicz M., Zeichner J.A., Eichenfield L.F., Herbert A.A., Jarratt M., Lucky A.W., et al. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr 2008, 152:854-859.
100. Cork M.J., Danby S.G., Vasilopoulos Y., Hadgraft J., Lane M.E., Moustafa M., et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009, 129:1892-1908.
101. Rehal B., Armstrong A. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS One 2011, 6:e17520.